Clinical Trials Logo

Clinical Trial Summary

The purpose of this open-label, randomized, two-period, two-treatment (single doses of 10 mg SHR0302 fasted or fed), crossover study was to evaluate the effect of a high-fat meal on the pharmacokinetics of SHR0302 and mass balance study in 14 healthy subjects.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02892370
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Chengyu Guan, MD
Phone 86-21-50118402
Email guanchengyu@hrs.com.cn
Status Recruiting
Phase Phase 1
Start date August 2016
Completion date October 2016

See also
  Status Clinical Trial Phase
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT01076205 - Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis N/A
Enrolling by invitation NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Enrolling by invitation NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT01087125 - Abatacept Pregnancy Exposure Registry
Recruiting NCT03690466 - Ultrasound Treatment of Rheumatoid Arthritis N/A
Recruiting NCT03312465 - Anatomical Shoulder Domelock System Study N/A
Recruiting NCT01942174 - VACcination In Methotrexate Treated Rheumatoid Arthritis Patients Phase 3
Completed NCT02139345 - TC-A Registration Study N/A
Recruiting NCT03699293 - NSAIDs vs. Coxibs in the Presence of Aspirin Phase 4
Active, not recruiting NCT02648035 - EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis
Completed NCT00069342 - Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
Completed NCT02885181 - Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate Phase 2
Not yet recruiting NCT03061877 - Anxiety Depression and Rheumatoid Arthritis
Not yet recruiting NCT03421184 - Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus N/A
Not yet recruiting NCT03254966 - Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients Phase 2
Recruiting NCT02930343 - Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy Phase 4
Recruiting NCT02820038 - Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A